Verona Gets $400M Boost from Oxford Finance, Hercules Capital for COPD Candidate

Verona Pharma, a biotech working on treating chronic obstructive pulmonary disease, has been given a financial boost of up to $400 million from two capital firms, the company announced Tuesday.